Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
Davis, Z and Miller, J(2023). Generation of pembrolizumab scFv. Bio-protocol Preprint. bio-protocol.org/prep2389.
Davis, Z., Felices, M., Lenvik, T., Badal, S., Walker, J. T., Hinderlie, P., Riley, J. L., Vallera, D. A., Blazar, B. R. and Miller, J. S.(2021). Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation. Blood Advances 5(4). DOI: 10.1182/bloodadvances.2019001110
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Spinning
Post a Question
0 Q&A
Spinning
This protocol preprint was submitted via the "Request
a Protocol" track.